Integration of 68Ga-PSMA-PET/CT in Radiotherapy Planning for Prostate Cancer Patients

Purpose To assess the role of 68 Gallium-labeled-prostate-specific membrane antigen PET/CT ( 68 Ga-PSMA-PET/CT) in risk group definition and radiotherapy planning in the initially planned definitive radiotherapy (RT) for prostate cancer patients. Methods The clinical data of 191 prostate cancer patients treated with definitive intensity-modulated RT were retrospectively analyzed. All patients were initially staged with thoracoabdominal CT and...